As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Defining customer value to drive innovation in design and construction | Will Lichtig, Chief of Staff at The Boldt Company
Built Environment Matters
24 minutes
2 years ago
Defining customer value to drive innovation in design and construction | Will Lichtig, Chief of Staff at The Boldt Company
Will Lichtig, Chief of Staff at The Boldt Company joins Technical Director Adrian La Porta on this episode of the Built Environment Matters podcast.We learn how Will's twenty-five years of experience as a construction lawyer allowed him to see the failings of the design and construction industry firsthand. Will now uses this knowledge to reshape the construction industry in a way that promotes project success. In his role at The Boldt Company, he is now a recognised leader in the lean and int...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
